Matrix metalloproteinase-9, transforming growth factor-β1, and tumor necrosis factor-α plasma levels in chronic pancreatitis

Indian Journal of Gastroenterology

Volumn 32, Issue 2, 2013, Pages 103-107

  Manjari, K Sri ^a   Jyothy, A ^a   Vidyasagar, A ^b   Prabhakar, B ^c   Nallari, Prathibha ^d   Venkateshwari, A ^a  

^a OSMANIA UNIVERSITY   (India)

^b Department of Gastroenterology   (India)

^c OSMANIA GENERAL HOSPITAL   (India)

^d OSMANIA UNIVERSITY   (India)

Author keywords

Extracellular matrix; Pancreatic fibrosis; Pancreatic stellate cells

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; CHRONIC PANCREATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING;

EID: 84876114601     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-012-0299-5     Document Type: Article

References (18)

1. Goodman AJ, Gress FG. The endoscopic management of pain in chronic pancreatitis. Gastroenterol Res Pract. 2012; 2012: 1-5.
2. Lindley KJ. Chronic pancreatitis. Indian J Pediatr. 2006; 73: 907-12.
3. Werb Z. ECM and cell surface proteolysis regulating cellular ecology. Cell. 1997; 91: 439-42.
4. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990; 6: 597-641.
5. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998; 175: 76-83.
6. Mews P, Phillips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002; 50: 535-41.
7. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999; 274: 21491-4.
8. Aysel K, Mehmet I, Şeval A, Seyfettin K, Engin U, Ali U. Serum TNF-alpha levels in acute and chronic pancreatitis. Eur J Gen Med. 2009; 6: 103-7.
9. Ebihara I, Nakamura T, Shimada N, Koide H. Increased plasma matrix metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1998; 32: 544-50.
10. Yokota T, Denham W, Murayama K, Pelham C, Joehl R, Bell RH Jr. Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis. J Surg Res. 2002; 104: 106-11.
11. Bartram U, Speer CP. The role of transforming growth factor in lung development and disease. Chest. 2004; 125: 754-65.
12. Menke A, Adler G. TGFβ-induced fibrogenesis of the pancreas. Int J Gastrointest Cancer. 2002; 31: 41-6.
13. Phan SH. Fibroblast phenotypes in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003; 29: S87-92.
14. Szuster-Ciesielska A, Daniluk J, Kandefer-Zerszen M. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis. Arch Immunol Ther Exp (Warsz). 2000; 48: 301-17.
15. Zhukov NA, Shirinskaia NV, Dolgikh TI, Akhmedov VA. Dynamics of expression of cytokines and lactoferrin in patients with chronic alcohol pancreatitis and chronic relapsing pancreatitis. Eksp Klin Gastroenterol. 2003; 5: 67-71.
16. Nakao A. Is TGF-beta1 the key to suppression of human asthma? Trends Immunol. 2001; 22: 115-8.
17. Howat WJ, Holgate ST, Lackie PM. TGF-beta isoform release and activation during in vitro bronchial epithelial wound repair. Am J Physiol Lung Cell Mol Physiol. 2002; 282: L115-23.
18. O'Kane S, Ferguson MW. Transforming growth factors and wound healing. Int J Biochem Cell Biol. 1997; 29: 63-78.